Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?

The vasodilator-stimulated phosphoprotein-phosphorylation (VASP-P) flow-cytometric assay is mainly used in clinical trials to measure thienopyridine effects. However, there are remarkable differences in the reported optimal cut-offs, ranging from 48-61% platelet reactivity index (PRI). We therefore...

Full description

Saved in:
Bibliographic Details
Published inThrombosis and haemostasis Vol. 107; no. 3; p. 538
Main Authors Freynhofer, Matthias K, Bruno, Veronika, Willheim, Martin, Hübl, Wolfgang, Wojta, Johann, Huber, Kurt
Format Journal Article
LanguageEnglish
Published Germany 01.03.2012
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The vasodilator-stimulated phosphoprotein-phosphorylation (VASP-P) flow-cytometric assay is mainly used in clinical trials to measure thienopyridine effects. However, there are remarkable differences in the reported optimal cut-offs, ranging from 48-61% platelet reactivity index (PRI). We therefore investigated whether a lack of standardisation might explain the differences in the cut-offs. We measured VASP-P in 62 individuals. PRI was calculated using the mean, geometric mean and median fluorescence intensities (FI). Stability of the blood-samples (time-to-assay, 0-2 days) and stability of the processed samples (0-120 minutes) within the recommended time-span were tested. Time-to-assay significantly influenced the PRI (p<0.001): the PRI from mean FI after two days was lower compared to values on day 1 (52 ± 22.9 vs. 57.7 ± 24.1, p<0.001). The PRI from the geometric mean FI after two days was lower compared to day 0 as well as day 1 (51.3 ± 23 vs. 58.2 ± 24.2 and vs. 59.1 ± 23.7, both p<0.001). The PRI from median FI was stable over time (day 0: 59.1 ± 25%, day 1: 59.7 ± 24.1% and day 2: 56.4 ± 23.9%, all p=ns). Furthermore, the lag time of the processed samples significantly altered the PRI (all p<0.001) with a maximum difference for PRI based on geometric mean FI after 90 minutes compared to baseline (Δ=3.92%PRI, p<0.001). The differences in the reported cut-offs might be explained by a lack of standardisation. More precise standardisation is inevitable, as the PRI significantly depends on the method of calculation, the time-to-assay as well as on the lag time after processing. Tolerably stable results were obtained for the PRI from the median FI.
AbstractList The vasodilator-stimulated phosphoprotein-phosphorylation (VASP-P) flow-cytometric assay is mainly used in clinical trials to measure thienopyridine effects. However, there are remarkable differences in the reported optimal cut-offs, ranging from 48-61% platelet reactivity index (PRI). We therefore investigated whether a lack of standardisation might explain the differences in the cut-offs. We measured VASP-P in 62 individuals. PRI was calculated using the mean, geometric mean and median fluorescence intensities (FI). Stability of the blood-samples (time-to-assay, 0-2 days) and stability of the processed samples (0-120 minutes) within the recommended time-span were tested. Time-to-assay significantly influenced the PRI (p<0.001): the PRI from mean FI after two days was lower compared to values on day 1 (52 ± 22.9 vs. 57.7 ± 24.1, p<0.001). The PRI from the geometric mean FI after two days was lower compared to day 0 as well as day 1 (51.3 ± 23 vs. 58.2 ± 24.2 and vs. 59.1 ± 23.7, both p<0.001). The PRI from median FI was stable over time (day 0: 59.1 ± 25%, day 1: 59.7 ± 24.1% and day 2: 56.4 ± 23.9%, all p=ns). Furthermore, the lag time of the processed samples significantly altered the PRI (all p<0.001) with a maximum difference for PRI based on geometric mean FI after 90 minutes compared to baseline (Δ=3.92%PRI, p<0.001). The differences in the reported cut-offs might be explained by a lack of standardisation. More precise standardisation is inevitable, as the PRI significantly depends on the method of calculation, the time-to-assay as well as on the lag time after processing. Tolerably stable results were obtained for the PRI from the median FI.
Author Bruno, Veronika
Wojta, Johann
Huber, Kurt
Freynhofer, Matthias K
Willheim, Martin
Hübl, Wolfgang
Author_xml – sequence: 1
  givenname: Matthias K
  surname: Freynhofer
  fullname: Freynhofer, Matthias K
  email: matthias.freynhofer@meduniwien.ac.at
  organization: 3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria. matthias.freynhofer@meduniwien.ac.at
– sequence: 2
  givenname: Veronika
  surname: Bruno
  fullname: Bruno, Veronika
– sequence: 3
  givenname: Martin
  surname: Willheim
  fullname: Willheim, Martin
– sequence: 4
  givenname: Wolfgang
  surname: Hübl
  fullname: Hübl, Wolfgang
– sequence: 5
  givenname: Johann
  surname: Wojta
  fullname: Wojta, Johann
– sequence: 6
  givenname: Kurt
  surname: Huber
  fullname: Huber, Kurt
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22274403$$D View this record in MEDLINE/PubMed
BookMark eNo1jztPAzEQhF0EkQd01Mh_wGCvH8nRIBQBQYpEE2gj33kNRnfnk-0U-fccSihWu9-sZqSZk0kfeyTkRvA7IQy_322EYLxi3ICckBmXijMDSk_JPOcfzoVRlb4kUwBYKsXljJRPm6MLrS0xsVxCdxhPdHT4jnmcIcWCoWdnTMfxG2JPbc72SENPh5GxL5mOYtPGIbj4lbB9oC5iprnY3tnkQj7ZOlsKpscrcuFtm_H6vBfk4-V5t96w7fvr2_ppyxqtqsKgbqyX1i29BFx5WXtoatDWCYnLP0SvjTTGay0AnOfO1Eqs6gqMd4gNLMjtKXc41B26_ZBCZ9Nx_18ffgFX-2Ed
CitedBy_id crossref_primary_10_1160_TH11_12_0876
crossref_primary_10_1016_j_jcin_2014_09_007
crossref_primary_10_3390_jcm12031149
crossref_primary_10_1016_j_jcin_2013_06_011
crossref_primary_10_3109_09537104_2012_704650
crossref_primary_10_1160_TH12_10_0758
crossref_primary_10_5482_HAMO_13_11_0055
crossref_primary_10_1007_s10354_012_0148_2
crossref_primary_10_1080_09537104_2018_1478399
crossref_primary_10_1111_j_1538_7836_2012_04838_x
crossref_primary_10_1160_TH15_02_0179
crossref_primary_10_3109_09537104_2013_827781
crossref_primary_10_1517_14656566_2014_953054
crossref_primary_10_1016_j_ijcard_2014_04_208
crossref_primary_10_3109_09537104_2012_689037
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1160/TH11-09-0623
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 22274403
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
0R~
0VX
123
1KJ
4.4
53G
5RE
AAQQT
ABJNI
ABOCM
ACGFO
ACGFS
ACNUY
AENEX
AFFNX
AGCGI
AHRSK
ALMA_UNASSIGNED_HOLDINGS
BR6
C45
CGR
CS3
CUY
CVF
DU5
EBS
ECM
EIF
EJD
F5P
H13
J5H
NPM
OVD
P2P
RTC
RTE
SJN
TEORI
X7M
ZGI
ZXP
ID FETCH-LOGICAL-c549t-2bcaf3ad7f32e8f3bf2cb25ad13e7f3bfef56366f55122df0d6b418b926fdeec2
ISSN 0340-6245
IngestDate Mon Jul 21 05:59:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c549t-2bcaf3ad7f32e8f3bf2cb25ad13e7f3bfef56366f55122df0d6b418b926fdeec2
PMID 22274403
ParticipantIDs pubmed_primary_22274403
PublicationCentury 2000
PublicationDate 2012-03-01
PublicationDateYYYYMMDD 2012-03-01
PublicationDate_xml – month: 03
  year: 2012
  text: 2012-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Thrombosis and haemostasis
PublicationTitleAlternate Thromb Haemost
PublicationYear 2012
SSID ssj0016495
Score 2.1260068
Snippet The vasodilator-stimulated phosphoprotein-phosphorylation (VASP-P) flow-cytometric assay is mainly used in clinical trials to measure thienopyridine effects....
SourceID pubmed
SourceType Index Database
StartPage 538
SubjectTerms Blood Specimen Collection - standards
Blood Specimen Collection - statistics & numerical data
Cell Adhesion Molecules - metabolism
Cell Separation
Coronary Artery Disease - diagnosis
Coronary Artery Disease - drug therapy
Coronary Artery Disease - epidemiology
Flow Cytometry
Humans
Microfilament Proteins - metabolism
Observer Variation
Phosphoproteins - metabolism
Phosphorylation - drug effects
Platelet Activation - drug effects
Platelet Function Tests - methods
Platelet Function Tests - standards
Platelet Function Tests - statistics & numerical data
Prospective Studies
Reference Standards
Ticlopidine - administration & dosage
Ticlopidine - adverse effects
Ticlopidine - analogs & derivatives
Vasodilator Agents - metabolism
Title Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?
URI https://www.ncbi.nlm.nih.gov/pubmed/22274403
Volume 107
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2RUJcKt60POQDtyqwdRw3y6WCCrRCKqdt6a2KXyQiiVfN9lD-En-SGdvJRktBhcNGG1uxksxnZ2Y88w0hrw2gSAuVJ4WQWcIlzxM5kzJhqTlkIuNGzjB3-OSLmJ_yz-fZ-WTycxS1dLWSb9SPG_NK_keq0AZyxSzZf5DsMCg0wH-QLxxBwnC8lYzPis7pqka7OYGp2mApLlAgl6Xr4OcpGKo2iaeX1yHsbR_U5cJn-0VOVb9hoDBzSjuwvmt0EmhnusHNECN-9hvPxbkRCrgoL10jHfKaoA--LEzj4MKuGiWWmOu2dDaAwxcYr4pu7V9F8gPvsD0zSNT7ff2hqOq6NKHcc6A7GECI-_sfjqX3X391tf1WxC9wdGBgJEgfwdUnbmEGAgusksOiHGrhRvSloyU2C2wwvy_9AmMlF3N0-SKxQkhjHqFg2XgYYPIv59Nb9G4QcfddW2QLTBKssYqOobhhJbgv8DM8S59jIaZvx7eE3NNxmA07xuszi_tkJxoi9H1A1QMyMe1Dcvckhlo8IqubwUX_Di7qwUWrlvbgotA4Atc7itCiG9CiAVpHj8npp4-L43kSS3QkKuOzVcKkKmxa6EObMpPbVFqmJMsKfQBzHU-NzUQqhAXFnDFtp1pIfpDLGRNWG6PYE7LdutY8IzTTnr9QKhiGW9DaBRgPAj0WWuVS6V3yNLyvi2XgYbno3-TeH3uek3trxL0gdyxMfPMStMiVfOXl9wv8DXiw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vasodilator-stimulated+phosphoprotein-phosphorylation+assay+in+patients+on+clopidogrel%3A+does+standardisation+matter%3F&rft.jtitle=Thrombosis+and+haemostasis&rft.au=Freynhofer%2C+Matthias+K&rft.au=Bruno%2C+Veronika&rft.au=Willheim%2C+Martin&rft.au=H%C3%BCbl%2C+Wolfgang&rft.date=2012-03-01&rft.issn=0340-6245&rft.volume=107&rft.issue=3&rft.spage=538&rft_id=info:doi/10.1160%2FTH11-09-0623&rft_id=info%3Apmid%2F22274403&rft_id=info%3Apmid%2F22274403&rft.externalDocID=22274403
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-6245&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-6245&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-6245&client=summon